Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections

OBJECTIVES: The designer antibacterial peptide A3-APO is efficacious in mouse models of Escherichia coli and Acinetobacter baumannii systemic infections. Here we compare the efficacy of the peptide with that of imipenem and colistin in A. baumannii wound infections after burn injury. METHODS: CD-1 m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ostorhazi, Eszter, Rozgonyi, Ferenc, Sztodola, Andras, Harmos, Ferenc, Kovalszky, Ilona, Szabo, Dora, Knappe, Daniel, Hoffmann, Ralf, Cassone, Marco, Wade, John D., Bonomo, Robert A., Otvos, Laszlo
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2010
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2980952/
https://ncbi.nlm.nih.gov/pubmed/20810424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkq337
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares